RecallDepth
Class I Terminated

Natpara (parathyroid hormone) for Injection, 75 mcg, 2 pack medication cartridges, Rx only, For subcutaneous use only, Manufactured for: Shire-NPS Pharmaceuticals, Inc., Lexington, MA NDC 68875-0204-02

This recall has been terminated (originally issued October 2, 2019).

Company
Shire Human Genetic Therapies, Inc.
Recall Initiated
September 12, 2019
Posted
October 2, 2019
Recall Number
D-0037-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
15,075
Firm Location
Lexington, MA, United States
Official Source
View on FDA website ↗

Reason for Recall

Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing

Distribution

Product was distributed throughout the United States.

Lot / Code Info

06628462, exp 5/31/2020 06651000, exp 9/30/2020 06661659, exp 6/30/2020 07110125, 07301073, exp 10/31/2020 07200435, 7/31/2020 07482211, exp 12/31/2020 07630714, exp 3/31/2021 NX170002DA, exp 12/31/2019 NX17004DA, exp 3/31/2020 NX17007DA, NX17007DB, NX17008DA exp 4/30/2020 NX17010DA, NX17012DA, exp 6/30/2020

More recalls by Shire Human Genetic Therapies, Inc.

View all recalls by this company →

Other recent Class I Drug recalls